| Name | Title | Contact Details |
|---|
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.
Cholestech Corporation (Cholestech) is a provider of diagnostic tools and information for immediate risk assessment and therapeutic monitoring of heart disease and diabetes. The Company manufactures and markets the LDX System in the United States and
Remington Medical Equipment is a Markham, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Based in Silicon Valley, CA, NDS Surgical Imaging is a global leader in designing and manufacturing medical imaging and informatics systems.
Gauss Surgical, Inc. was founded in 2011 and is located in Los Altos, California. The company was started with the vision of leveraging mobile devices in the OR as medical devices, to significantly improve the quality of perioperative care.